Defeating Alzheimer's disease and other dementias: a priority for European science and society, Lancet Neurol, vol.15, issue.5, pp.455-532, 2016. ,
Vascular risk factors and dementia: how to move forward? Neurology, vol.72, pp.368-74, 2009. ,
Potential for primary prevention of Alzheimer's disease: an analysis of population-based data, Lancet Neurol, vol.13, issue.8, pp.788-94, 2014. ,
The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam Study, BMC Med, vol.13, p.132, 2015. ,
Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study, Diabetes Care, vol.32, issue.1, pp.169-74, 2009. ,
Midlife cardiovascular risk factors and risk of dementia in late life, Neurology, vol.64, issue.2, pp.277-81, 2005. ,
Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease, Ann Intern Med, vol.137, issue.3, p.12160362, 2002. ,
Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease, Arch Neurol, vol.62, issue.10, pp.1556-60, 2005. ,
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease, Neuroepidemiology, vol.17, issue.1, 1998. ,
Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later, Dement Geriatr Cogn Disord, vol.28, issue.1, pp.75-80, 2009. ,
Relation of plasma lipids to Alzheimer disease and vascular dementia, Arch Neurol, vol.61, issue.5, pp.705-719, 2004. ,
Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study, Neurology, vol.45, issue.6, p.7783883, 1995. ,
Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment, J Epidemiol Community Health, vol.65, issue.11, pp.949-57, 2011. ,
Serum cholesterol and risk of Alzheimer disease: a community-based cohort study, Neurology, vol.65, issue.7, 2005. ,
Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study, Arterioscler Thromb Vasc Biol, vol.20, issue.10, p.11031212, 2000. ,
Metabolic syndrome and dementia risk in a multiethnic elderly cohort, Dement Geriatr Cogn Disord, vol.24, issue.3, pp.185-92, 2007. ,
Metabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Ageing, J Neurol Neurosurg Psychiatry, vol.81, issue.4, pp.433-473, 2010. ,
Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study, Alzheimer Dis Assoc Disord, vol.20, issue.2, pp.93-100, 2006. ,
High total cholesterol levels in late life associated with a reduced risk of dementia, Neurology, vol.64, issue.10, pp.1689-95, 2005. ,
Association of higher levels of highdensity lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease, Arch Neurol, vol.67, issue.12, pp.1491-1498, 2010. ,
Midlife vascular risk factors and their association with dementia deaths: results from a Norwegian prospective study followed up for 35 years, J Neurol Sci, vol.324, issue.1, pp.124-154, 2013. ,
Cardiovascular risk factors and dementia mortality: 40 years of follow-up in the Seven Countries Study, J Neurol Sci, vol.280, issue.1, pp.79-83, 2009. ,
Plasma lipids and cerebral small vessel disease, Neurology, vol.83, issue.20, p.25320101, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01196098
Midlife cardiovascular risk factors and brain morphology in identical older male twins, Neurology, vol.52, issue.6, p.10214731, 1999. ,
Significant association between leukoaraiosis and metabolic syndrome in healthy subjects, Neurology, vol.69, issue.10, p.17538033, 2007. ,
Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study, Stroke, vol.41, issue.4, pp.600-606, 2010. ,
Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population, Neuroepidemiology, vol.22, issue.6, p.14598854, 2003. ,
Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study, Arch Neurol, vol.64, issue.1, p.17210816, 2007. ,
The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study, Brain, vol.128, pp.1093-101, 2005. ,
Prodromal Alzheimer's disease: successive emergence of the clinical symptoms, Ann Neurol, vol.64, issue.5, pp.492-500, 2008. ,
A cognitive screening battery for dementia in the elderly, J Clin Epidemiol, vol.53, issue.10, p.11027929, 2000. ,
, Diagnostic and statistical manual of mental disorders, 2000.
Studies of illness in the aged. The Index of ADL: a standardized measure of biological and psychosocial function, JAMA, vol.185, p.14044222, 1963. ,
Scales to measure competence in everyday activities, Psychopharmacol Bull, vol.24, issue.4, p.3074322, 1988. ,
A Guttman health scale for the aged, J Gerontol, vol.21, issue.4, p.5918309, 1966. ,
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, vol.34, issue.7, p.6610841, 1984. ,
Vascular dementia: diagnostic criteria for research studies, Report of the NINDS-AIREN International Workshop. Neurology, vol.43, issue.2, p.8094895, 1993. ,
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, vol.18, issue.6, p.4337382, 1972. ,
APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study, Neurology, vol.64, issue.9, pp.1531-1539, 2005. ,
URL : https://hal.archives-ouvertes.fr/inserm-00175952
Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study, Stat Med, vol.23, issue.24, pp.3803-3823, 2004. ,
Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix, Heredity (Edinb), vol.95, issue.3, pp.221-228, 2005. ,
Sex and race differences in the association between statin use and the incidence of Alzheimer disease, JAMA Neurol, vol.74, issue.2, pp.225-257, 2017. ,
Representation of exposures in regression analysis and interpretation of regression coefficients: basic concepts and pitfalls, Nephrol Dial Transplant, vol.29, issue.10, pp.1806-1820, 2014. ,
Checking the Cox model with cumulative sums of Martingale-based residuals, Biometrika, vol.80, issue.3, pp.557-72, 1993. ,
Sex differences in the associations between lipid levels and incident dementia, J Alzheimers Dis, vol.34, issue.2, pp.519-547, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00782575
Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study, Arch Int Med, vol.163, issue.9, pp.1053-1060, 2003. ,
Metabolic syndrome and risk of dementia in older adults, J Am Geriatr Soc, vol.58, issue.3, p.20398117, 2010. ,
Lipids and adipokines as risk factors for Alzheimer's disease, J Alzheimers Dis, vol.29, issue.1, pp.151-158, 2012. ,
Relationships between cholesterol, apolipoprotein E polymorphism and dementia: a cross-sectional analysis from the PAQUID study, Neuroepidemiology, vol.19, issue.3, pp.141-149, 2000. ,
Incidence of dementia over three decades in the Framingham Heart Study, N Engl J Med, vol.374, issue.6, pp.523-555, 2016. ,
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers, Lancet Neurol, vol.12, issue.2, pp.207-223, 2013. ,
Silent brain infarcts and the risk of dementia and cognitive decline, N Engl J Med, vol.348, issue.13, pp.1215-1237, 2003. ,
Apolipoprotein E in Alzheimer's disease and other neurological disorders, Lancet Neurol, vol.10, issue.3, pp.241-52, 2011. ,
Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample, Lancet, vol.346, issue.8987, 1995. ,
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease, Nat Genet, vol.45, issue.12, p.24162737, 2013. ,
Associations between potentially modifiable risk factors and Alzheimer disease: a Mendelian randomization study, PLoS Med, vol.12, issue.6, p.1001841, 2015. ,
Statins for the prevention of dementia, Cochrane Database Syst Rev, vol.1, p.3160, 2016. ,
Vascular risk factors and cognitive disorders, Rev Neurol (Paris), vol.169, issue.10, pp.757-64, 2013. ,
Pravastatin and cognitive function in the elderly. Results of the PROSPER study, J Neurol, vol.257, issue.1, pp.85-90, 2010. ,
, MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial, Lancet, vol.360, issue.9326, pp.7-22, 2002.
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, Lancet, vol.376, issue.9753, pp.1670-81, 2010. ,
The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day, Am J Cardiol, vol.79, issue.1, p.9024733, 1997. ,
Statins, cognition, and dementiasystematic review and methodological commentary, Nat Rev Neurol, vol.11, issue.4, pp.220-229, 2015. ,
Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study, J Neurol Neurosurg Psychiatry, vol.80, issue.1, pp.13-20, 2009. ,
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease, BMC Med, vol.5, p.17640385, 2007. ,
Dementia in subjects aged 75 years or over within the PAQUID cohort: prevalence and burden by severity, Dement Geriatr Cogn Disord, vol.22, issue.1, pp.87-94, 2006. ,
Vascular risk factors and dementia revisited, J Neurol Neurosurg Psychiatry, vol.80, issue.11, 2009. ,
Guidelines for reporting methodological challenges and evaluating potential bias in dementia research, Alzheimers Dement, vol.11, issue.9, pp.1098-109, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01288885